India's Leading Pharmaceutical Company
Mr. Vinayak Dinesh Dendukuri Mr. Vinayak is the Co-founder & Director of NOVICK Biosciences. Under his guidance and leadership, NOVICK has established a system that delivers high-quality pharmaceutical product development services, assuring sound fiscal operations. Mr. Vinayak is also a Director of Brane Enterprises, a company emphasizing natural language (no coding) and machine learning. Prior to this role, Mr. Vinayak was Drug Safety Scientist at Quintiles, leading Phase II and Phase III clinical trials across the globe for major Pharmaceutical companies. Mr. Vinayak also served as a Scientist in several positions at Sanofi Pasteur and GlaxoSmithKline, USA. He completed his Bachelor's in Biotechnology from Rochester Institute of Technology, USA, and his Master's in Microbiology, Immunology, and Biochemistry from the University of Rochester, USA.
Mr. Upendar Mekala Reddy Vice President – iLabs Capital
Upendar is an Investment Manager at iLabs Group. He holds MBA Degree with specialisation in finance from Indian Institute of Management Kozhikode (IIMK), Bachelor of Technology in Computer Science Engineering from JNTU - Hyderabad and FRM Certification from Global Association of Risk Professionals (GARP) Upendar has over 15 years of experience spanning project and structured finance, fund raising, Mergers and Acquisitions and Investment Banking. He has executed transactions across sectors including Power (Renewable & Non-renewable), Pharmaceuticals, Roads, Manufacturing, Cement, Real estate, Ports, etc Prior to iLabs Group, Upendar was working as Vice President with Edelweiss Financial Services handling the wholesale and structured lending business. He also worked as Assistant Vice President with IL&FS Financial Services and Senior Manager with L&T Infrastructure Finance in the Project Finance Team
Mr. Krishna Yeachuri Commerce Graduate and Chartered Accountant.
Worked with reputed companies such as Coromandel Fertilizers Ltd, DCL Polyesters Ltd, GCI SA – a Belgium company, RA Chempharma (part of Advent now), Aurore Life Sciences of companies.
Ms. Shanmugam Hemalatha - She is a Commerce graduate with. C.S. (Inter), ICWA (Inter) and having 17 years of experience in Bafna. She is heading entire gamut of commercial initiatives for the organization
Mr. B Kamlesh Kumar -He is graduate in B.A. and Chartered Accountant. He is specialized in Finance, taxation and capital market. He brings with him rich experience in Taxation, accounts and Capital Market, Finance and Banking.
Mr. P K Sundaresan- He is a Cost and Management Accountancy (FCMA) and Company Secretary (FCS) having experience of more than 40 years in Finance, Commercial and Operation & General Management with Intensive experience in Process industries.
Mrs. AkilaPriya C. Raju - She is a Partner at KCR Enterprise LLP .She holds a Masters in Law from New York University School of Law , New York, NY.
Akila has over 7 Years of Experience in the Legal Field .Prior to KCR Enterprise LLP, Akila worked at J.Sagar and Associates, Bangalore office, in their corporate Law Department , with a focus on Private Equity and real estate transactions. Subsequently, Akila worked as the in-house Legal Counsel of Bangalore based Pharmaceutical company , Strides Shasun Ltd, where she led the legal team in setting up the companies Australia business .Post her move to Hyderabad, she focused representing clients in civil litigation matters. Akila is passionate about utilizing her legal skills to further Social Causes. While in New York, she Volunteered at an immigration Clinic where worked pro bono on several asylum petitions as well as fighting deportation and removal notices.
He has an Electronics and Communication Engineering degree from Maharishi Dayanand University, Rohtak and an MBA from International Management Institute, Delhi.
Mrs. Ravichandran Chitra – Chitra is the Founder and CEO of REXA Corporate Solutions P Ltd & REXA Insurance Broking Services P Ltd.
She has over three decades of experience in: